MELI vs RGNX · P/E 43, rev $19.01B vs rev $114.4M
MercadoLibre Inc. (MELI) versus Regenxbio Inc (RGNX) — a side-by-side from cached financials, not a winner call.
MercadoLibre Inc. (MELI) is a internet retail company listed on NASDAQ.
Regenxbio Inc (RGNX) is a biotechnology company listed on US.
Latest reported MELI revenue for 2026-06-30 was $19.01B. Net income was $883.0M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
Latest reported RGNX revenue for 2026-06-30 was $114.4M. Net income was -$67.3M. RGNX currently screens at market cap $440.4M.
MELI currently screens at market cap $82.73B and trailing P/E 43.1. RGNX currently screens at market cap $440.4M.
Not investment advice. Open the MELI and RGNX stock pages for the full models.
Not investment advice.